Initial Experience With High-Risk Patients Excluded From Clinical Trials: Safety of Short-Term Anticoagulation After Left Atrial Appendage Closure Device [Original Article]

Conclusions—
With careful multidisciplinary evaluation, a short course of OAC after WATCHMAN device implantation in patients with previous spontaneous major bleeding events is associated with low risk of recurrent spontaneous major bleeding.

Source: Circulation: Arrhythmia and Electrophysiology - May 24, 2016 Category: Cardiology Authors: Barakat, A. F., Hussein, A. A., Saliba, W. I., Bassiouny, M., Tarakji, K., Kanj, M., Jaber, W., Rodriguez, L. L., Grimm, R., Hussain, M. S., Russman, A., Uchino, K., Wisco, D., Rasmussen, P., Bain, M., Vargo, J., Zuccaro, G., Gottesman, D., Lindsay, B. D. Tags: Arrhythmias, Atrial Fibrillation, Anticoagulants, Intracranial Hemorrhage Original Article Source Type: research